ReviewMetabolic brain disease2021
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.
Susan J van Rensburg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it